ArticleClinical rheumatology2020

Overall survival in patients with rheumatoid arthritis and solid malignancies receiving biologic disease-modifying antirheumatic therapy.

Xerxes Pundole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.